宏观经济点评 2025 年 12 月 11 日 美联储进一步降息空间或相对有限 宏观研究团队 ——12 月 FOMC 会议点评 何宁（分析师） 潘纬桢（分析师） hening@kysec.cn 证书编号：S0790522110002 panweizhen@kysec.cn 证书编号：S0790122110044 事件：美联储于北京时间 12 月 11 日凌晨 3 点发布 12 月 FOMC 会议声明，宣布 降息 25bp。 声明及发布会要点 1. 美联储在此次会议上宣布再次降息 25bp，降息后利率水平在 3.5%-3.75%区间。 资产负债表政策方面，美联储认为准备金已经降至充足水平，将根据需要启动短 期国债的购买（初期 400 亿美元/月）。 2. 再次降息 25bp，维持就业市场走弱风险上升判断。在声明中，美联储的措辞 同 10 月份相比基本未变，即认为美国经济正在以温和的速度扩张。就业方面， 美联储认为就业增长有所放缓，失业率在 9 月份略有上升，且近期指标也印证了 这一趋势，因此就业下行风险有所上升；通胀方面，仍维持通胀率处于较高水平 的判断。在委员投票中，美联储官员们的分歧更加显性化，除了特朗普新 ...

Group 1: CPI Analysis - November CPI year-on-year increased to 0.7%, up 0.5 percentage points from the previous value of 0.2%[1] - November food CPI month-on-month rose by 0.5%, an increase of 0.2 percentage points from the previous value[3] - Core CPI month-on-month fell to -0.3%, down 0.3 percentage points from the previous month, remaining above seasonal levels for two consecutive months[3] Group 2: PPI Insights - November PPI year-on-year decreased to -2.2%, a decline of 0.1 percentage points from the previous value of -2.1%[4] - Coal mining and washing industry PPI month-on-month increased by 4.1%, significantly up from the previous value of 1.6%[4] - Input factors and real estate chain contributed to a greater drag on PPI year-on-year, with respective contributions of -0.5 and -0.7 percentage points[4] Group 3: Future Inflation Predictions - December CPI is expected to rise to around 1.0% year-on-year, with a month-on-month increase of approximately 0.2%[6] - December PPI is anticipated to show a year-on-year increase, with the average for 2025 expected to be around -2.6%[6] - The future trajectory of PPI will depend on international commodity prices and domestic policy strength[6] Group 4: Risk Factors - Potential risks include unexpected policy changes and significant fluctuations in commodity prices[6]

Core Insights - The report highlights a rebound in export growth, with November exports increasing by 5.9% year-on-year, indicating strong resilience in foreign trade [5][7][9] - The construction sector is experiencing a divergence in performance, with traditional and new infrastructure projects working in tandem [20][23] - The automotive sector is witnessing significant growth, particularly in modular supply and die-casting businesses, with expectations of continued high profit growth [25][26] Group 1: Export and Trade Insights - November import growth was recorded at 1.9% year-on-year, while exports saw a notable increase of 5.9% year-on-year, marking a recovery from previous declines [5][6] - The trade surplus also improved, with a year-on-year increase of 14.7%, reflecting a robust trade environment [5][6] - The report emphasizes that China's export strength is driven by high cost-performance products, with machinery and high-tech products showing significant growth [8][9] Group 2: Construction Sector Analysis - The construction sector's fixed asset investment decreased by 1.7% year-on-year, with infrastructure investment growing by only 1.5%, indicating a slowdown [20][21] - Major state-owned enterprises in the construction sector reported a revenue decline of 4.4% year-on-year, highlighting the challenges faced due to reduced new contracts and prolonged payment cycles [21][22] - The report suggests focusing on opportunities in overseas construction, urban renewal, digital construction, and power engineering as key growth areas [22][23] Group 3: Automotive Sector Developments - The automotive sector is experiencing rapid growth, with the company transitioning successfully to a modular supplier, expecting significant revenue increases [25][26] - The market for stamping parts is substantial, with a domestic market size of approximately 300 billion, and the company is positioned to capture a larger market share [26][27] - The report anticipates continued high growth in the automotive sector, driven by partnerships with major automotive brands and the expansion of product offerings [27][28] Group 4: Electronics Sector Insights - The electronics sector, particularly in ODM, is set to benefit from the AI wave, with the company positioned as a leader in smartphone ODM with a revenue of 464 billion [29][30] - The report outlines a strategic focus on expanding into new growth areas such as smart glasses and automotive electronics, leveraging AI technology [30][31] - The company is expected to see significant revenue growth, with projections of 462.08 billion, 546.44 billion, and 663.31 billion for 2025-2027 [29][31]

Investment Rating - The report assigns a "Buy" rating for the company, marking its first coverage [1]. Core Insights - The company has successfully transformed into a modular supplier, with its die-casting business entering a harvest period. Revenue is projected to grow significantly, with net profits expected to reach 9.32 billion, 13.34 billion, and 16.97 billion yuan from 2025 to 2027, respectively [5][61]. - The company has seen rapid revenue growth, from 800 million yuan in 2021 to an estimated 4.2 billion yuan in 2024, indicating a strong upward trajectory in the automotive structural parts sector [5][20]. - The company is positioned to become a leading player in the domestic automotive structural parts market, benefiting from the rise of domestic brands and the acceptance of integrated die-casting technology [6][61]. Summary by Sections 1. Company Overview - Founded in 2004, the company has evolved from mold manufacturing to stamping and die-casting, establishing a comprehensive production capability across various automotive components [12]. - The company has a concentrated shareholding structure, with significant ownership by its founders, which enhances management stability and operational efficiency [16]. 2. Market Potential - The stamping parts market in China is approximately 300 billion yuan, with a global market size of about 15 trillion yuan, indicating substantial growth opportunities [6]. - The integrated die-casting market is expected to exceed 10 billion yuan in 2022 and reach 100 billion yuan by 2025, driven by cost reduction and efficiency improvements [35]. 3. Competitive Advantages - The company has a strong focus on technology and management, which has led to high profitability levels. Its production strategy is based on demand-driven expansion, ensuring efficient capacity utilization [48]. - The company has established relationships with key clients, including major domestic automotive manufacturers, which are expected to drive future revenue growth [51][55]. 4. Financial Projections - Revenue is projected to grow from 2.6 billion yuan in 2023 to 11.2 billion yuan by 2027, with a compound annual growth rate (CAGR) of 66.6% from 2020 to 2024 [8][20]. - The company's net profit margin is expected to improve, with net profit projected to reach 1.7 billion yuan by 2027, reflecting a robust growth trajectory [8][61].

Investment Rating - The report suggests a focus on "innovation-driven" and "steady growth" strategies within the pharmaceutical sector, indicating a positive investment outlook for the industry [3][4]. Core Insights - The North Exchange's pharmaceutical and biotechnology sector comprises 21 companies, all classified as specialized and innovative, with a significant proportion being national and provincial champions [2][16]. - The report emphasizes the potential of innovative drugs, high-end medical devices, and robust generics as key investment areas, highlighting the importance of unique products and market share advantages [3][4]. - The medical device sector has shown the highest market value growth in 2025, with an increase of 130.47%, while traditional Chinese medicine has faced performance challenges [28][32]. Summary by Sections Industry Overview - The North Exchange's pharmaceutical sector includes five sub-sectors: traditional Chinese medicine, medical devices, medical aesthetics, biological products, and chemical pharmaceuticals [12][24]. - The average market capitalization of the 21 companies in this sector reached 3.643 billion yuan as of December 1, 2025, reflecting a year-to-date increase of 41.97% [21][23]. Sub-sector Analysis - The medical device industry led the market value growth in 2025, with a total market value increase from 6.818 billion yuan at the end of 2024 to 15.713 billion yuan by December 1, 2025 [28]. - The chemical pharmaceutical sector also performed well, with notable companies like Deyuan Pharmaceutical showing a revenue increase of 22% year-on-year in the first three quarters of 2025 [4][34]. Company Case Studies - **Innovative Drugs**: Norsland's gene therapy drug NL003 is nearing approval, targeting a significant patient population with a new treatment method [4][9]. - **Medical Devices**: Weizhu Zhiyuan focuses on smart orthopedic surgical navigation systems, emphasizing the importance of unique technology and market positioning [4][11]. - **Generics**: Deyuan Pharmaceutical is transitioning from generics to innovative drugs, with a solid historical performance and a focus on diabetes and hypertension treatments [4][34]. Performance Metrics - The report notes that the average PE TTM for the pharmaceutical sector was 32X as of December 1, 2025, with the medical device sector showing a higher valuation at 78X [15][55]. - Companies like Jinbo Biological and Norsland have seen significant stock price increases, with Jinbo's stock rising by 170.68% and Norsland by 113.10% in 2025 [41][42].

1. Report Industry Investment Rating There is no information provided regarding the report industry investment rating in the given content. 2. Core Viewpoints of the Report - The export growth rate rebounded and turned positive in November 2025, indicating strong resilience in foreign trade. The root cause of China's exports continuously exceeding expectations lies in the high cost - effectiveness of Chinese goods, which is the result of domestic "involution" and technological progress. Although the export growth rate may slow down in December due to the high base in 2024, the high cost - effectiveness of Chinese goods will remain unchanged, and China's exports will remain high for a long time. In the bond market, with the revision of economic expectations, bond yields are expected to rise trend - wise [1][5][6][7]. 3. Summary by Relevant Catalogs 3.1 11 - month Import and Export Data Highlights - In November 2025, the year - on - year growth rates of imports, exports, and trade surplus all rebounded. Exports increased by 5.9% year - on - year and 8.2% month - on - month, and the export amount reached a high level since 2021 [3][4]. 3.2 Reasons for the Rebound of Export Growth Rate in November - The negative year - on - year export growth in October was mainly due to the base dislocation in September and October 2024 and trade frictions. After the China - US talks in Kuala Lumpur and the meeting in Busan, the conclusion of trade agreements promoted the return of the export rhythm to normal. After the elimination of base disturbances, the export growth rate rebounded and turned positive in November [5]. 3.3 Analysis of Export Structure - As of November 2025, the cumulative year - on - year growth of mechanical and electrical products exports was 8.0%, and that of high - tech product exports was 6.6%, showing relatively high - speed growth. In contrast, the cumulative year - on - year decrease of labor - intensive goods was 4.2%, indicating a transformation from labor - intensive to high - tech products in exports, which may reflect China's industrial transformation and upgrading [6]. 3.4 Forecast of Export Growth Rate in December - Due to the high base caused by the rush to export in December 2024 after Trump's election and the resulting increase in trade policy uncertainty, the export growth rate in December 2025 may be under pressure. However, the high cost - effectiveness of Chinese goods will not change [7]. 3.5 Market Conditions - On December 8, the long - term yield first rose and then fell, showing an "M" - shaped trend. After the Politburo meeting mentioned the implementation of a more proactive fiscal policy and a moderately loose monetary policy, the long - term yield quickly declined. Attention should be paid to the Fed's interest rate decision and the Central Economic Work Conference [8]. 3.6 Bond Market Viewpoints - In the context of the revision of economic expectations, bond yields are expected to rise trend - wise. For stock and bond allocation, the previous views are maintained [9].

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights the adjustment of the interest rate shock scenario by the Basel Committee (BCBS), reducing the parallel upward shift from 250 basis points (BP) to 225 BP, which is expected to improve the ΔEVE (Economic Value of Equity) to Tier 1 Capital ratio for major banks [4][5] - It is estimated that this adjustment could release approximately CNY 1 trillion in capacity for 30-year local government bonds and CNY 1.5 trillion for 15-year bonds [6][8] - The report anticipates that the regulatory requirements for interest rate risk indicators may be relaxed in 2026, potentially alleviating the pressure on banks [7] Summary by Sections Interest Rate Shock Adjustment - The BCBS has revised the interest rate shock scenario, reducing the parallel upward shift from 250 BP to 225 BP, which is expected to enhance the ΔEVE/Tier 1 Capital ratio by 0.92% to 1.57% for major banks [4][12] - Major banks such as ICBC, CCB, ABC, and BOC are projected to see improvements in their ΔEVE ratios, with specific improvements of 1.13%, 1.36%, 1.57%, and 0.92% respectively [5][12] Capacity Release for Local Government Bonds - The adjustment in interest rate shock is expected to release approximately CNY 870 billion for 30-year local government bonds and CNY 1.16 trillion for 15-year bonds [5][14] - If the Ministry of Finance injects capital into ICBC and ABC in 2026, it could further improve their ΔEVE ratios and release additional capacity for local government bonds [6][15] Regulatory Environment - The report suggests that regulatory constraints on banks may be relaxed, with a potential reduction in the required shock levels and a possible easing of the upper limit on risk indicators [7] - The report notes that major banks sold approximately CNY 740 billion in 7-10 year bonds and CNY 850 billion in 20-30 year bonds from January to November 2025, indicating a shift in their bond portfolio strategy [16] Investment Recommendations - The report recommends a bottom-up approach focusing on large state-owned banks, with specific beneficiaries identified as Agricultural Bank of China and Industrial and Commercial Bank of China [8] - Core investments are suggested in leading comprehensive banks, with China Merchants Bank and Industrial Bank highlighted as key beneficiaries [8]

Core Insights - The report highlights a steady recovery in AIDC demand in China, driven by significant capital expenditures from major companies like Alibaba, which reported a 34% year-on-year revenue growth in its cloud segment and an 80.1% increase in capital expenditures [35][38]. - The potential approval of the H200 chip for export to China is expected to further stimulate domestic AI model development and increase demand for domestic AIDC solutions [42][43]. Macroeconomic Overview - The macroeconomic analysis indicates a continued trend of moderate export recovery, with November exports increasing by 5.9% year-on-year, a significant rebound from the previous decline of 1.1% [6][7]. - The report notes that while there is a recovery in export figures, the overall trend remains cautious due to high base effects and potential global trade slowdowns [9][10]. Industry Analysis - The telecommunications sector is experiencing a positive shift, with AIDC demand expected to accelerate as companies ramp up investments in AI and cloud infrastructure [35][39]. - The report suggests that the approval of the H200 chip could lead to a resurgence in demand for AI servers and related infrastructure, benefiting various segments within the AIDC ecosystem [42][43]. Investment Recommendations - Recommended stocks in the AIDC space include companies like Huazhong Technology, Aofei Data, and Guanghuan New Network, which are positioned to benefit from the anticipated growth in AIDC demand [40][44]. - The report also identifies potential beneficiaries in the cooling and power supply sectors related to AIDC, suggesting a broad investment opportunity across the supply chain [40][44]. Institutional Research Trends - Recent institutional research has shown increased interest in sectors such as home appliances, building materials, and computing, indicating a shift in market focus [24][25]. - The report emphasizes the importance of institutional research as a critical component of investment decision-making, providing timely and multidimensional insights into industry dynamics [24].

Investment Rating - The industry investment rating is "Overweight" (maintained) [1] Core Insights - The report highlights strong growth in AIDC demand driven by significant capital expenditures from Alibaba, which reported a 34% year-on-year revenue increase in Q2 FY2026 and an 80.10% increase in total capital expenditures [3] - Century Internet's IDC business shows robust growth with a 21.7% year-on-year revenue increase in Q3 2025, indicating a positive trend in AIDC demand [4] - The potential approval of the H200 chip is expected to boost domestic AIDC demand, enhancing the AI ecosystem in China [5] Summary by Sections AIDC Demand and Growth - Alibaba's capital expenditures reached 31.5 billion yuan in Q2 FY2026, up 80.10% year-on-year, with a focus on AI cloud computing infrastructure [3] - Century Internet's operational capacity increased to 783 MW, with a quarterly growth of 109 MW, reflecting a strong demand for IDC services [4] Chip Supply and Market Impact - The U.S. government's potential approval for the H200 chip could significantly enhance domestic AIDC demand and support the growth of the AI ecosystem in China [5] Investment Recommendations - Recommended stocks in AIDC data centers include Guanghuan New Network, Aofei Data, and others, while beneficiaries include WanGuo Data and Century Internet [6] - For AIDC cooling solutions, recommended stocks include Yingweike, with beneficiaries like Yinlun Co. and others [6] - In AIDC power supply, beneficiary stocks include Kehua Data and others [6]

业 研 究 《"AI+卫星"的共振—行业周报》 -2025.12.7 《字节发布豆包手机助手，重视端侧 AI 投 资 机 遇 — 行 业 点 评 报 告 》 -2025.12.1 《谷歌和阿里火出圈，全球 AI 持续共 振—行业周报》-2025.11.30 蒋颖（分析师） 雷星宇（联系人） jiangying@kysec.cn ——行业点评报告 投资评级：看好（维持） 行业走势图 数据来源：聚源 -24% 0% 24% 48% 72% 96% 2024-12 2025-04 2025-08 通信 沪深300 相关研究报告 2025 年 12 月 09 日 "H200 芯片或放开"下的投资机会梳理 leixingyu@kysec.cn 证书编号：S0790124040002 英伟达 H200 芯片有望获对华出口许可，国内 AI 模型发展或将加速 2025 年 12 月 9 日，据央视网、中国基金报消息，美国总统特朗普在"真实社交" 媒体平台发文称，在确保美国国家安全的前提下，将"允许英伟达向中国及其他 国家的合格客户交付其 H200 芯片产品"，Blackwell 芯片以及即将发布的 Rubin 芯片则不在获批 ...